Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1 | Journal of Medicinal Chemistry
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy | Clinical Epigenetics | Full Text
LSD1 inhibitors induce neuronal differentiation of Merkel cell carcinoma by disrupting the LSD1-CoREST complex and activating TGFβ signaling | bioRxiv
Summary of LSD1/KDM1A inhibitors in clinical trials and clinical use. a | Download Table
LSD1 inhibitors in clinical trials | Download Scientific Diagram
Summary of LSD1/KDM1A inhibitors in clinical trials and clinical use. a | Download Table
LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma | EMBO Molecular Medicine
LSD1 inhibitors in clinical trials. | Download Table
LSD1/KDM1A inhibitors in clinical trials: advances and prospects | Journal of Hematology & Oncology | Full Text
Advances toward LSD1 inhibitors for cancer therapy | Future Medicinal Chemistry
Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines | PLOS ONE
Irreversible TCP-based LSD1 inhibitors 19-24. | Download Scientific Diagram
Cancers | Free Full-Text | LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target | HTML
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy | Leukemia
Advances toward LSD1 inhibitors for cancer therapy | Future Medicinal Chemistry
Natural products as LSD1 inhibitors for cancer therapy - ScienceDirect
Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors - ScienceDirect
LSD1/KDM1A inhibitors in clinical trials: advances and prospects | Journal of Hematology & Oncology | Full Text
Frontiers | LSD1 Activates PI3K/AKT Signaling Through Regulating p85 Expression in Prostate Cancer Cells
LSD1/KDM1A inhibitors in clinical trials: advances and prospects | Journal of Hematology & Oncology | Full Text
Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1 | Journal of Medicinal Chemistry
Figure 1 from Design, synthesis and biological activity of 3-oxoamino-benzenesulfonamides as selective and reversible LSD1 inhibitors. | Semantic Scholar
